AST-120 Used to Treat Mild Hepatic Encephalopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

June 30, 2010

Conditions
Mild Hepatic Encephalopathy
Interventions
DRUG

AST-120

AST-120

Trial Locations (38)

10021

Weill Medical College of Cornell, New York

10595

New York Medical College, Valhalla

14642

University of Rochester Medical Center, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

19140

Temple University Hospital, Philadelphia

19141

Albert Einstein Medical Center, Division of Hepatology, Philadelphia

20010

Washington Hospital Center, Washington D.C.

23249

McGuire DVAMC, Richmond

29425

Medical University of Southern Carolina, Charleston

32224

Mayo Clinic Jacksonville, Jacksonville

32610

University of Florida College of Medicine, Gainesville

33136

University of Miami, Division of Hepatology / Center for Liver Disease, Miami

35294

University of Alabama at Birmingham, Birmingham

40202

University of Louisville, Louisville

44109

Case Western Reserve / MetroHealth Medical Center, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45267

University of Cincinatti, Cincinnati

52246

VA Medical Center / University of Iowa Hospital and Clinics, Iowa City

60611

Northwestern University, Feinberg School of Medicine, Chicago

60612

Rush University Medical Center, Chicago

70112

Tulane University Health Sciences Center, New Orleans

71201

Delta Research Partners, LLC, Monroe

75246

Baylor University Medical Center, Dallas

77030

Advanced Liver Therapies, St. Luke's Episcopal Hospital/Baylor College of Medicine, Houston

79761

Permian Research Foundation, Odessa

84132

University of Utah Health Sciences Center, Salt Lake City

85054

Mayo Clinic Arizona, Phoenix

92037

Scripps Clinic, San Diego

92101

UCSD Medical Center, San Diego

92161

UCSD Medical Center, La Jolla

93721

UCSF - Fresno Community Regional Medical Center, Fresno

94115

California Pacific Medical Center, San Francisco

06520

Yale University School of Medicine, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconnes Medical Center, Harvard Medical School, Boston

01655

University of Massachusetts Memorial Medical Center, Worcester

03756

Dartmouth Hitchcock Medical Center, Lebanon

75390-9151

UT Southwestern Medical Center, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ocera Therapeutics

INDUSTRY

NCT00867698 - AST-120 Used to Treat Mild Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter